Search For "us fda"
US-FDA's approval of mix and match COVID booster shots confirmation of eff
Updated : 4 years, 5 months ago IST
Moscow [Russia], October 21 (ANI): Following the decision by the US Food and Drug Administration allowing individuals to receive booster shots that are different from their first COVID-19 vaccine doses, the Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) reiterated that
Read More
CPhI and Informa Pharma Intelligence concluded the 3rd Biopharma Conclave
Updated : 4 years, 5 months ago IST
Hyderabad (Telangana) [India], October 1 (ANI/PRNewswire): Informa Pharma Intelligence, one of the leading business intelligence providers and knowledge partners, has today concluded the 3rd edition of the Biopharma Conclave conducted by CPhI.
Read More
US FDA authorizes Pfizer's Covid booster shots for elderly, high-risk Amer
Updated : 4 years, 6 months ago IST
Washington [US], September 23 (ANI): US Food and Drug Administration (FDA) on Wednesday (local time) authorized booster shots of the Pfizer COVID-19 vaccine for those aged 65 and older and adults at high risk.
Read More
Glenmark Pharmaceuticals receives ANDA approval for Clindamycin Phosphate
Updated : 4 years, 6 months ago IST
Mumbai (Maharashtra) [India], September 21 (ANI/PR Newswire): Glenmark Pharmaceuticals Ltd. (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Clindamycin Phosphate Foam, 1%, the generic version of Evoclin®1 Foam, 1%, of Mylan Pharm
Read More
US FDA: No Pfizer booster shots for 16 and above, approved only for people
Updated : 4 years, 6 months ago IST
Washington [US], September 18 (ANI): The US Food and Drug Administration advisory (FDA) committee on Friday (local time) voted unanimously to authorize Pfizer booster shots for use in people aged 65-plus and high-risk patients following a prior failed vote to approve third shots for all p
Read More
US: FDA gives full approval to Pfizer-BioNTech COVID 19 vaccine
Updated : 4 years, 7 months ago IST
Washington [US] August 23 (ANI): The US Food and Drug Administration (FDA) on Monday gave full approval to Pfizer's COVID-19 vaccine.
Read More
Pfizer and BioNTech announce submission of Initial data to US FDA to suppo
Updated : 4 years, 7 months ago IST
New York [US], August 17 (ANI): Pfizer and BioNTech announced that they have submitted Phase 1 data to the United States Food and Drug Administration (FDA) to support the evaluation of a third, or booster dose of the companies' COVID-19 vaccine for future licensure.
Read More
Growing and glowing with Cozmoderm Clinic
Updated : 4 years, 8 months ago IST
New Delhi [India], June 30 (ANI/SRV Media): Cozmoderm Clinic is redefining the new generation of aesthetics and beauty industry by serving dermatological and cosmetic solutions in a holistic environment.
Read More
We respect US FDA decision, but it won't impact India's vaccine plan: Cent
Updated : 4 years, 9 months ago IST
New Delhi [India], June 11 (ANI): Reacting to the United States Food and Drug Administration (FDA)'s rejection of Bharat Biotech's Covaxin jab for emergency use authorization, the Union Health Ministry on Friday said that it respects the decision taken by the authority but it will not hav
Read More
Third member of US FDA advisory panel resigns over Alzheimer's drug approv
Updated : 4 years, 9 months ago IST
Washington [US], June 11 (ANI): A third member of the US Food and Drug Administration (FDA) expert advisory panel resigned from the body after it approved a controversial Alzheimer's drug named Aduhelm recently.
Read More
US FDA okays first new Alzheimer's drug in nearly 2 decades
Updated : 4 years, 9 months ago IST
Washington [US], June 8 (ANI): The United States Food and Drug Administration (FDA) has approved a new drug for Alzheimer's, the first new medicine against the disease in almost two decades.
Read More
Glenmark Pharmaceuticals launches Rufinamide Tablets USP, 200 mg and 400 m
Updated : 4 years, 9 months ago IST
Mumbai (Maharashtra) [India], June 1 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark) has launched Rufinamide Tablets USP, 200 mg and 400 mg, a therapeutic equivalent of Banzel® Tablets, 200 mg and 400 mg of Eisai, Inc.
Read More